Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke
After a three week trial, a jury found that PeaceHealth and Ralph Weiche, MD, acted in accordance with medical protocols in diagnosing Patricia Parker with a psychiatric condition, given her unusual symptoms.
Women less likely to receive DCD heart transplants
Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one.
Mayo Clinic develops AI capable of substantially improving dementia diagnoses
With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.

Elective revascularization with PCI or CABG provides long-term cardiovascular benefits, new meta-analysis confirms

Researchers evaluated data from 25 different randomized clinical trials, sharing their findings virtually at EuroPCR 2021.

Dapagliflozin fails to reduce the risk of organ failure or death among COVID-19 patients

Patients given the SGLT2 inhibitor did experience improved outcomes, the researchers noted, but none of the differences were statistically significant.

A milestone for Medtronic: Low-risk TAVR patients treated with Evolut ‘doing exceptionally well’ after 2 years

The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients.

Abbott’s new self-expanding TAVR system gains CE mark approval

The solution has still only been approved in the United States for investigational use.

Finerenone limits AFib in patients with chronic kidney disease, Type 2 diabetes

This secondary analysis of data from the FIDELIO-DKD trial was presented May 17 at ACC.21 and published in the Journal of the American College of Cardiology.

Alcohol—even just one drink—increases the risk of AFib

The study's authors believe they are the first group to investigate the real-time relationship between alcohol consumption and AFib events.

Full COVID-19 vaccination to be required at HIMSS21 in Las Vegas

The new requirement covers all attendees, including exhibitors and HIMSS employees. The organization is still determining how it will validate each person's status.

The greatest benefit: Omecamtiv mecarbil improves outcomes the most for patients with severe heart failure

Researchers explored data from the GALACTIC-HF trial to evaluate how the severity of a patient's reduced ejection fraction impacts the benefits of omecamtiv mecarbil.

Clinical

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke

Women less likely to receive DCD heart transplants

Mayo Clinic develops AI capable of substantially improving dementia diagnoses

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving